Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 07, 2015 3:59 AM ET

Professional Services

Company Overview of General Genetics Corporation

Company Overview

General Genetics Corporation provides genetic, clinical, and forensic laboratory services. It provides forensic testing services in the areas of DNA paternity testing, DNA predisposition testing, ancestral origins DNA ancestry testing, infidelity DNA testing, DNA maternity testing, siblingship SNA testing, twin zygosity DNA testing, grandparent/aunt/uncle DNA testing, missing parent DNA testing, immigration DNA testing, prenatal paternity testing, and Y-STR male lineage DNA testing. The company also provides clinical testing services in the areas of predisposition testing for immune systems, cardiovascular conditions, aging, and cancers; and plavix testing for preventing clot-related events,...

MSC3ARP, Box 30001

3655 Research Drive

Las Cruces, NM 88003

United States





Key Executives for General Genetics Corporation

Chief Executive Officer and Member of the Board
Chief Financial Officer
Executive Vice President of North American Business Development
Chief Operating Officer of International Division
Chief Growth Officer and Executive Vice President
Compensation as of Fiscal Year 2014.

General Genetics Corporation Key Developments

General Genetics Corporation Appoints Tom Arena as EVP, Chief Growth Officer

General Genetics Corporation announced the addition of Tom Arena as EVP, Chief Growth Officer. Mr. Arena brings a wealth of experience to the position and complements the existing executive leadership team. Mr. Arena is a seasoned Sales and Marketing executive with over 25 years' experience in sales, business development and strategic planning. Most recently, Mr. Arena was the Chief Strategy Officer of

General Genetics Corporation Announces Management Changes

General Genetics Corporation announced its has expanded the board of directors, the joining board members were Rayburn Thompson, Thomas J. Ridge, Dr. Arthur B. Laffer, Stefano Ciampolini. Mr. Thompson is the Chief Executive Officer of General Genetics Corporation (GGC) and has been in healthcare executive management positions for nearly 30 years. Prior to becoming CEO of GGC, he was the Chief Administrative Officer for Solstas Lab Partners. Mr. Ridge is the CEO of Ridge Global. Mr. Ridge was the first Assistant to the President for Homeland Security and on January 24, 2003, was appointed the first Secretary of the U.S. Department of Homeland Security. Dr. Laffer is the founder and Chairman of Laffer Associates, an economic research and consulting firm that provides global investment-research services to institutional asset managers, pension funds, financial institutions and corporations. Dr. Laffer is a founding member. Mr. Ciampolini is Adjunct Professor of Imperial College Business School in London and co-founder of Healthcare Capital Partners, a London based private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures. R. James Bentley, Executive Vice President of North American Business Development.­ A chemist by training, Mr. Bentley has spent his over 30-year career in technical operations and sales roles for various laboratories. Prior to Bode he was in business development, consulting and general management positions for a variety of other laboratory, industrial hygiene and environmental management companies. Kevin Camilleri, Chief Operating Officer ­ International Division ­ Mr. Camilleri is an entrepreneur and co-founder of EasyDNA. As President of EasyDNA. He started his career in the Business Advisory Division of PriceWaterhouseCoopers. Kelly Bewick, Chief Financial Officer ­ Ms. Bewick held several corporate controller positions, including most recently for a manufacturer of synthetic DNA called Intrexon. Ms. Bewick was also director of financial analysis and compliance for Luna Innovations.

Similar Private Companies By Industry

Company Name Region
Hanzmilla Management Consultancy United States
Law Office of Joseph R Scarpello United States
Applied Value LLC United States
Wickwire Gavin, P.C. United States
Acton & Snyder, LLP United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact General Genetics Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at